Lexitas Pharma Services Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lexitas Pharma Services Inc. - overview
Established
2011
Location
Durham, NC, US
Primary Industry
Biotechnology
About
Based in North Carolina, US, and founded in 2011 by co-founders Chris Brown, Saiid Davari, Chad Ice, and Joanna Williams, Lexitas Pharma Services Inc. operates as a contract research organization (CRO) that provides clinical trial services and consulting to pharmaceutical and biotechnology companies in the ophthalmology therapeutic sector. In July 2022, NovaQuest Capital Management acquired Lexitas Pharma Services Inc. As of July 2022, the company is led by its CEO George Magrath.
Lexitas Pharma Services Inc. provides various services such as clinical operations services including clinical trial management, site selection, site qualification, regulatory document collection, site management, recruitment strategy development, investigator training, and other key clinical operations tasks; data management services; medical monitoring services; medical monitoring; medical affairs and commercialization strategies for dry eye disease, glaucoma, cataract, uveitis, pediatric myopia, diabetic macular edema, age-related macular degeneration, and retinitis pigmentosa. Following the acquisition, Lexitas Pharma Services Inc. plans to continue the growth and capability expansion.
Current Investors
NovaQuest Capital Management
Primary Industry
Biotechnology
Sub Industries
Consulting Services, Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.lexitas.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Lexitas Pharma Services Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Lexitas Pharma Services Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.